Quality of health care of atopic eczema in Germany: results of the national health care study AtopicHealth
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: The successful treatment of atopic eczema (AE) should result in the improvement of both physical symptoms and patient′s quality of life (QoL). This study was conducted using a sample of dermatologists throughout Germany. This is due to dermatologists being the main health care providers of AE. Objectives: Obtaining reliable data on quality of care of AE from both the patient's and the physician's perspective. Methods: This cross‐sectional study assessed: the individual clinical history; dermatology‐specific QoL (DLQI); state of health (EQ‐5d‐VAS); treatments; burden caused by disease and treatment; patient‐defined treatment benefit (PBI). Results: Data from 1678 adult patients (60.5% female, mean age: 38.4 ± 15.9) were analysed. The most frequently used treatments during the last five years were emollients (90.4%) and topical corticosteroids (85.5%). In this study, 75.8% of the patients felt only moderately or not at all impaired by their treatment. The mean DLQI (0 = minimum–30 = maximum QoL impairment) was 8.5 ± 6.5. The EQ‐5d‐VAS (100 = best possible) was 63.6 ± 22.0 on average. 26.6% reported suffering ‘often’ or ‘every night’ from sleeplessness due to severe itching. Mean PBI was 2.4 ± 1.1 (4 = maximum benefit). Conclusions: This study provides first data on the health care of adults with AE in Germany at a national level and reveals the need for a more effective care. Whereas most patients consider their treatment‐related burden as low, the daily burden of the disease seems to be high: one third reports sleeplessness due to itching which indicates insufficient therapeutic regimes in these cases. A better implementation of the German national guideline for AE and a systematic analysis of the difficulties causing its limited effects is needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosnow, R. L., & Rosenthal, R. (1996) · Psychological Methods · doi:10.1037/1082-989x.1.4.331 · Cited by 761
Management of Atopic Dermatitis in the Pediatric Population
Krakowski, A. C., Eichenfield, L. F., & Dohil, M. A. (2008) · Pediatrics · doi:10.1542/peds.2007-2232 · Cited by 205
Burden of Atopic dermatitis in Canada
Barbeau, M., & Bpharm, H. L. (2006) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2004.02345.x · Cited by 83
Quality of life of children with atopic dermatitis and their families
McKenna, S. P., & Doward, L. C. (2008) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e3282ffd6cc · Cited by 74
Cited by
Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
Ruzicka, T., Hanifin, J. M., Furue, M., Pulka, G., Mlynarczyk, I., Wollenberg, A., Galus, R., Etoh, T., Mihara, R., Yoshida, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606490 · Cited by 592
Simpson, E. L., Bieber, T., Eckert, L., Wu, R., Ardeleanu, M., Graham, N. M. H., Pirozzi, G., & Mastey, V. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.10.043 · Cited by 302
Kabashima, K., Furue, M., Hanifin, J. M., Pulka, G., Wollenberg, A., Galus, R., Etoh, T., Mihara, R., Nakano, M., & Ruzicka, T. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.03.018 · Cited by 248
Unmet medical needs in chronic, non-communicable inflammatory skin diseases
Ujiie, H., Rosmarin, D., Schön, M. P., Ständer, S., Boch, K., Metz, M., Maurer, M., Thaci, D., Schmidt, E., Cole, C., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.875492 · Cited by 158
“There can be a significant effect on patient’s quality of life and sleep due to itch and pain (37).”
Background
Metadata
- Authors
- Langenbruch, A., Radtke, M., Franzke, N., Ring, J., Foelster‐Holst, R., & Augustin, M.
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2013-04-05
- Volume
- 28
- Issue
- 6
- Pages
- 719-726
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W2044423858
- Cited by
- 60
- References
- 4
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quality of health care of atopic eczema in Germany: results of the national health care study AtopicHealth. https://app.cochat.ai/papers/10.1111/jdv.12154
- The paper
- Langenbruch, A., Radtke, M., Franzke, N., Ring, J., Foelster‐Holst, R., & Augustin, M. (2014). Quality of health care of atopic eczema in Germany: results of the national health care study AtopicHealth. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.12154
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.